Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Cryopreserved Fibroblast and Mesenchymal Stem Cells (MSCs) Being Alternative Mitochondrial Donors for Mitochondrial Organelle Transplantation (MOT)

October 2024 Bioprinting, Bioprocessing, Cardiovascular, MedTech, Devices, & Materials, Tissue Engineering

The role of matrix stiffness and viscosity on lipid phenotype and fat lineage potential

September 2024 Bioprinting, Cell Therapy, Clinical, MedTech, Devices, & Materials, Tissue Engineering

Functional high capacity exosome-encapsulating bioinspired hydrogel promotes microvascular bed expansion in diabetic mice

August 2024 Bioprinting, Bioprocessing, Cardiovascular, Cell Therapy, Clinical, Dermal and Wound, Diabetes, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

Cell–Material Interactions in Covalent Adaptable Thioester Hydrogels

August 2024 Bioprinting, Bioprocessing, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Tissue Engineering

Droplet-based microfluidics for engineering shape-controlled hydrogels with stiffness gradient

August 2024 Bioprinting, Cancer, MedTech, Devices, & Materials, Tissue Engineering

Perovskites as Multiphoton Fluorescence Contrast Agents for In Vivo Imaging

August 2024 Bioprinting, Bioprocessing, Cell Therapy, Immunomodulation, MedTech, Devices, & Materials, Tissue Engineering

An Exosome-Laden Hydrogel Wound Dressing That Can Be Point-of-Need Manufactured in Austere and Operational Environments

August 2024 Bioprinting, Bioprocessing, Cell Therapy, Dermal and Wound, Exosomes / Extracellular Vesicles, MedTech, Devices, & Materials, Tissue Engineering

Paracrine signals influence patterns of fibrocartilage differentiation in a lyophilized gelatin hydrogel for applications in rotator cuff repair

August 2024 Bioprinting, Bioprocessing, Cell Therapy, Drug Screening, MedTech, Devices, & Materials, Tissue Engineering

Strategies for the Codelivery of Osteoclasts and Mesenchymal Stem Cells in 3D-Printable Osteochondral Scaffolds

August 2024 Bioprinting, Bioprocessing, Blood, MedTech, Devices, & Materials, Orthopedic, Pain, Tissue Engineering

Vascularization of Bioengineered Fat With Tunable Matrix Properties for Macro-Perfusion and Soft Tissue Reconstruction

August 2024 Bioprinting, Cardiovascular, MedTech, Devices, & Materials, Tissue Engineering
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email